Katja Maino

1.5k total citations · 1 hit paper
9 papers, 1.1k citations indexed

About

Katja Maino is a scholar working on Psychiatry and Mental health, Pharmacology and Biological Psychiatry. According to data from OpenAlex, Katja Maino has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 3 papers in Pharmacology and 3 papers in Biological Psychiatry. Recurrent topics in Katja Maino's work include Schizophrenia research and treatment (6 papers), Tryptophan and brain disorders (3 papers) and Treatment of Major Depression (3 papers). Katja Maino is often cited by papers focused on Schizophrenia research and treatment (6 papers), Tryptophan and brain disorders (3 papers) and Treatment of Major Depression (3 papers). Katja Maino collaborates with scholars based in Germany, Austria and United States. Katja Maino's co-authors include Michael Riedel, Norbert Müller, Werner Kissling, Markus Schwarz, Stefan Leucht, Stephan Heres, Ilja Spellmann, Sandra Dehning, John M. Davis and H-J Möller and has published in prestigious journals such as American Journal of Psychiatry, Psychological Medicine and Molecular Psychiatry.

In The Last Decade

Katja Maino

9 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

2006 628 citations Norbert Müller, Markus Schwarz et al. Molecular Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katja Maino Germany	7	554	429	328	170	122	9	1.1k
Ilja Spellmann Germany	21	707 1.3×	501 1.2×	581 1.8×	222 1.3×	164 1.3×	36	1.7k
J.M. Olivares Spain	25	325 0.6×	106 0.2×	1.1k 3.4×	225 1.3×	111 0.9×	96	2.0k
A. Klimke Germany	22	225 0.4×	113 0.3×	709 2.2×	247 1.5×	114 0.9×	79	1.7k
Krzysztof Kus Poland	18	130 0.2×	167 0.4×	113 0.3×	106 0.6×	42 0.3×	108	1.1k
Bruno Agustini Australia	13	285 0.5×	224 0.5×	203 0.6×	101 0.6×	79 0.6×	23	915
Romain Colle France	19	336 0.6×	180 0.4×	168 0.5×	238 1.4×	82 0.7×	84	1.2k
David M. Marks United States	15	126 0.2×	131 0.3×	345 1.1×	220 1.3×	80 0.7×	29	953
Alexander Kautzky Austria	27	384 0.7×	109 0.3×	457 1.4×	635 3.7×	82 0.7×	83	1.8k
Heidi J. Wehring United States	21	146 0.3×	60 0.1×	484 1.5×	105 0.6×	47 0.4×	49	1.2k
Daniel K. Hall‐Flavin United States	24	228 0.4×	88 0.2×	320 1.0×	351 2.1×	36 0.3×	47	1.7k

Countries citing papers authored by Katja Maino

Since Specialization

Citations

This map shows the geographic impact of Katja Maino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Maino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Maino more than expected).

Fields of papers citing papers by Katja Maino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Maino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Maino. The network helps show where Katja Maino may publish in the future.

Co-authorship network of co-authors of Katja Maino

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Maino. A scholar is included among the top collaborators of Katja Maino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Maino. Katja Maino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Heres, Stephan, et al.. (2012). Patients' acceptance of the deltoid application of risperidone long-acting injection. European Neuropsychopharmacology. 22(12). 897–901. 7 indexed citations

2.

Mendel, Rosmarie, Eva Traut‐Mattausch, Eva Jonas, et al.. (2011). Confirmation bias: why psychiatrists stick to wrong preliminary diagnoses. Psychological Medicine. 41(12). 2651–2659. 60 indexed citations

3.

Kissling, Werner, et al.. (2009). Long-term observation of patients successfully switched to risperidone long-acting injectable: A retrospective, naturalistic 18-month mirror-image study of hospitalization rates and therapy costs. International Journal of Psychiatry in Clinical Practice. 14(1). 53–62. 18 indexed citations

4.

Musil, Richard, Ilja Spellmann, Michael Riedel, et al.. (2008). SNAP-25 gene polymorphisms and weight gain in schizophrenic patients. Journal of Psychiatric Research. 42(12). 963–970. 30 indexed citations

5.

Maino, Katja, et al.. (2007). T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment. Psychiatry Research. 152(2-3). 173–180. 59 indexed citations

6.

Heres, Stephan, et al.. (2006). Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics. American Journal of Psychiatry. 163(2). 185–194. 291 indexed citations

7.

Müller, Norbert, Markus Schwarz, Sandra Dehning, et al.. (2006). The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Molecular Psychiatry. 11(7). 680–684. 628 indexed citations breakdown →

8.

Schwarz, Markus, Sandra Dehning, Anja Cerovecki, et al.. (2006). P.2.c.030 The COX-2 inhibitor celecoxib has therapeutic effects in major depression:results of a double-blind, placebo controlled, add-on study to reboxetine. European Neuropsychopharmacology. 16. S329–S329. 1 indexed citations

9.

Musil, Richard, Ilja Spellmann, Michael Riedel, et al.. (2006). P.3.c.035 SNAP-25 gene polymorphisms and weight gain in schizophrenic patients treated with atypical antipsychotics. European Neuropsychopharmacology. 16. S415–S415. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact